Based on Triton’s research report, the global male infertility market is estimated to progress in revenue at a CAGR of 4.81% during the forecast period 2023-2030.
Factors such as the growing adoption of assisted reproductive technologies and technological innovations fuel the male infertility market’s growth. Additionally, the rising acceptance of minimally invasive surgeries opens new avenues for the studied market. Another notable trend expected to widen the market scope is the increasing government reimbursement policies.
However, the high cost of treatment is anticipated to hamper the expansion of the male infertility market over the forecast period.
REGIONAL OUTLOOK
The global male infertility market encompasses Asia-Pacific, North America, Latin America, Europe, and the Middle East and Africa regions.
Globally, the Asia-Pacific is anticipated to emerge as the fastest-growing region during the forecast period. The region’s growth can be attributed to rising disposable income and collaboration among key players. Another trend that is expected to fuel the demand for infertility treatment is technological advancements, including microfluidic sperm function assays. In addition to these factors, the launch of fertility clinics is expected to further boost the Asia-Pacific male infertility market growth during the forecast period.
COMPETITIVE OUTLOOK
Notable companies in the male infertility market are Halotech DNA, EMD Serono Inc, Endo International Plc, Vitrolife, Bayer AG, Aytu BioPharma, Zydus Lifesciences Limited, CinnaGen Co, Sanofi SA, and Laboratory Corporation of America Holdings.
Sanofi SA develops and markets therapeutic products. Its business segments include specialty care, vaccines, and general medicines. The Sanofi Pasteur company, a major supplier of vaccines, serves as the main operating platform for the vaccines business unit. Consumer Healthcare (CHC) is another division, a stand-alone business unit with integrated R&D, manufacturing, service, and IT capabilities. Sanofi has operations across more than 90 countries, with headquarters in Paris, France.
1. Global Male Infertility Market - Summary
2. Industry Outlook
2.1. Parent Market Analysis
2.2. Impact Analysis On The Male Infertility Market
2.2.1. Covid-19 Impact
2.2.2. Ukraine-russia War Impact
2.3. Porter’s Five Forces Analysis
2.3.1. Threat Of New Entrants
2.3.2. Threat Of Substitutes
2.3.3. Bargaining Power Of Buyers
2.3.4. Bargaining Power Of Suppliers
2.3.5. Threat Of Competitive Rivalry
2.4. Market Maturity Analysis
2.5. Key Market Strategies
2.5.1. Collaborations
2.5.2. Product Launches
2.5.3. Mergers & Acquisitions
2.5.4. Business Divestitures & Expansions
2.6. Market Drivers
2.6.1. Prevalence Of Infertility
2.6.2. Use Of Assisted Reproductive Technologies
2.6.3. Technological Innovations And Advancements
2.7. Market Challenge
2.7.1. High Cost Of Treatment
2.8. Market Opportunities
2.8.1. Increasing Acceptance Of Minimally Invasive Surgeries
2.8.2. Growing Availability Of Infertility Treatment Drugs, Procedures, And Devices
2.8.3. Government Initiatives Toward Improving Reimbursement Policies
2.9. Analyst Perspective
3. Global Male Infertility Market – By Test Type
3.1. Dna Fragmentation Technique
3.2. Oxidative Stress Analysis
3.3. Microscopic Examination
3.4. Sperm Agglutination
3.5. Computer-assisted Semen Analysis
3.6. Sperm Penetration Assay
3.7. Other Test Types
4. Global Male Infertility Market – By Treatment
4.1. Assisted Reproductive Technology And Surgery
4.2. Medications
5. Global Male Infertility Market – By Regional Outlook
5.1. North America
5.1.1. Market By Test Type
5.1.2. Market By Treatment
5.1.3. Country Analysis
5.1.3.1. United States
5.1.3.1.1. United States Male Infertility Market Forecast & Prospects
5.1.3.2. Canada
5.1.3.2.1. Canada Male Infertility Market Forecast & Prospects
5.2. Europe
5.2.1. Market By Test Type
5.2.2. Market By Treatment
5.2.3. Country Analysis
5.2.3.1. United Kingdom
5.2.3.1.1. United Kingdom Male Infertility Market Forecast & Prospects
5.2.3.2. Germany
5.2.3.2.1. Germany Male Infertility Market Forecast & Prospects
5.2.3.3. France
5.2.3.3.1. France Male Infertility Market Forecast & Prospects
5.2.3.4. Italy
5.2.3.4.1. Italy Male Infertility Market Forecast & Prospects
5.2.3.5. Spain
5.2.3.5.1. Spain Male Infertility Market Forecast & Prospects
5.2.3.6. Poland
5.2.3.6.1. Poland Male Infertility Market Forecast & Prospects
5.2.3.7. Rest Of Europe
5.2.3.7.1. Rest Of Europe Male Infertility Market Forecast & Prospects
5.3. Asia-pacific
5.3.1. Market By Test Type
5.3.2. Market By Treatment
5.3.3. Country Analysis
5.3.3.1. China
5.3.3.1.1. China Male Infertility Market Forecast & Prospects
5.3.3.2. Japan
5.3.3.2.1. Japan Male Infertility Market Forecast & Prospects
5.3.3.3. India
5.3.3.3.1. India Male Infertility Market Forecast & Prospects
5.3.3.4. South Korea
5.3.3.4.1. South Korea Male Infertility Market Forecast & Prospects
5.3.3.5. Asean Countries
5.3.3.5.1. Asean Countries Male Infertility Market Forecast & Prospects
5.3.3.6. Australia & New Zealand
5.3.3.6.1. Australia & New Zealand Male Infertility Market Forecast & Prospects
5.3.3.7. Rest Of Asia-pacific
5.3.3.7.1. Rest Of Asia-pacific Male Infertility Market Forecast & Prospects
5.4. Latin America
5.4.1. Market By Test Type
5.4.2. Market By Treatment
5.4.3. Country Analysis
5.4.3.1. Brazil
5.4.3.1.1. Brazil Male Infertility Market Forecast & Prospects
5.4.3.2. Mexico
5.4.3.2.1. Mexico Male Infertility Market Forecast & Prospects
5.4.3.3. Rest Of Latin America
5.4.3.3.1. Rest Of Latin America Male Infertility Market Forecast & Prospects
5.5. Middle East And Africa
5.5.1. Market By Test Type
5.5.2. Market By Treatment
5.5.3. Country Analysis
5.5.3.1. United Arab Emirates
5.5.3.1.1. United Arab Emirates Male Infertility Market Forecast & Prospects
5.5.3.2. Turkey
5.5.3.2.1. Turkey Male Infertility Market Forecast & Prospects
5.5.3.3. Saudi Arabia
5.5.3.3.1. Saudi Arabia Male Infertility Market Forecast & Prospects
5.5.3.4. South Africa
5.5.3.4.1. South Africa Male Infertility Market Forecast & Prospects
5.5.3.5. Rest Of Middle East And Africa
5.5.3.5.1. Rest Of Middle East & Africa Male Infertility Market Forecast & Prospects
6. Competitive Landscape
6.1. Halotech Dna
6.1.1. Overview
6.1.2. Product Portfolio
6.2. Emd Serono Inc
6.2.1. Overview
6.2.2. Product Portfolio
6.2.3. Key Strengths
6.2.4. Key Challenges
6.3. Endo International Plc
6.3.1. Overview
6.3.2. Product Portfolio
6.3.3. Key Strengths
6.3.4. Key Challenges
6.4. Vitrolife
6.4.1. Overview
6.4.2. Product Portfolio
6.4.3. Key Strengths
6.4.4. Key Challenges
6.5. Bayer Ag
6.5.1. Overview
6.5.2. Product Portfolio
6.5.3. Key Strengths
6.5.4. Key Challenges
6.6. Aytu Biopharma
6.6.1. Overview
6.6.2. Product Portfolio
6.6.3. Key Strengths
6.6.4. Key Challenges
6.7. Zydus Lifesciences Limited
6.7.1. Overview
6.7.2. Product Portfolio
6.7.3. Key Strengths
6.7.4. Key Challenges
6.8. Cinnagen Co
6.8.1. Overview
6.8.2. Product Portfolio
6.8.3. Key Strengths
6.8.4. Key Challenges
6.9. Sanofi Sa
6.9.1. Overview
6.9.2. Product Portfolio
6.9.3. Key Strengths
6.9.4. Key Challenges
6.10. Laboratory Corporation Of America Holdings
6.10.1. Overview
6.10.2. Product Portfolio
6.10.3. Key Strengths
6.10.4. Key Challenges
7. Research Methodology & Scope
7.1. Research Scope & Deliverables
7.2. Sources Of Data
7.3. Research Methodology
Table List
Table 1: Global Male Infertility Market, By Regional Outlook, 2023-2030 (In $ Million)
Table 2: List Of Collaborations
Table 3: List Of Product Launches
Table 4: List Of Mergers & Acquisitions
Table 5: List Of Business Divestitures & Expansions
Table 6: Global Male Infertility Market, By Test Type, 2023-2030 (In $ Million)
Table 7: Global Male Infertility Market, By Treatment, 2023-2030 (In $ Million)
Table 8: Global Male Infertility Market, By Regional Outlook, 2023-2030 (In $ Million)
Table 9: North America Male Infertility Market, By Country Outlook, 2023-2030 (In $ Million)
Table 10: North America Male Infertility Market, By Test Type, 2023-2030 (In $ Million)
Table 11: North America Male Infertility Market, By Treatment, 2023-2030 (In $ Million)
Table 12: Europe Male Infertility Market, By Country Outlook, 2023-2030 (In $ Million)
Table 13: Europe Male Infertility Market, By Test Type, 2023-2030 (In $ Million)
Table 14: Europe Male Infertility Market, By Treatment, 2023-2030 (In $ Million)
Table 15: Asia-pacific Male Infertility Market, By Country Outlook, 2023-2030 (In $ Million)
Table 16: Asia-pacific Male Infertility Market, By Test Type, 2023-2030 (In $ Million)
Table 17: Asia-pacific Male Infertility Market, By Treatment, 2023-2030 (In $ Million)
Table 18: Latin America Male Infertility Market, By Country Outlook, 2023-2030 (In $ Million)
Table 19: Latin America Male Infertility Market, By Test Type, 2023-2030 (In $ Million)
Table 20: Latin America Male Infertility Market, By Treatment, 2023-2030 (In $ Million)
Table 21: Middle East And Africa Male Infertility Market, By Country Outlook, 2023-2030 (In $ Million)
Table 22: Middle East And Africa Male Infertility Market, By Test Type, 2023-2030 (In $ Million)
Table 23: Middle East And Africa Male Infertility Market, By Treatment, 2023-2030 (In $ Million)
Figure List
Figure 1: Market Maturity Analysis
Figure 2: Global Male Infertility Market, By Type, 2022 & 2030 (In %)
Figure 3: Global Male Infertility Market, By Dna Fragmentation Technique, 2023-2030 (In $ Million)
Figure 4: Global Male Infertility Market, By Oxidative Stress Analysis, 2023-2030 (In $ Million)
Figure 5: Global Male Infertility Market, By Microscopic Examination, 2023-2030 (In $ Million)
Figure 6: Global Male Infertility Market, By Sperm Agglutination, 2023-2030 (In $ Million)
Figure 7: Global Male Infertility Market, By Computer-assisted Semen Analysis, 2023-2030 (In $ Million)
Figure 8: Global Male Infertility Market, By Sperm Penetration Assay, 2023-2030 (In $ Million)
Figure 9: Global Male Infertility Market, By Other Test Types, 2023-2030 (In $ Million)
Figure 10: Global Male Infertility Market, By Treatment, 2022 & 2030 (In %)
Figure 11: Global Male Infertility Market, By Assisted Reproductive Technology And Surgery, 2023-2030 (In $ Million)
Figure 12: Global Male Infertility Market, By Medications, 2023-2030 (In $ Million)
Figure 13: Global Male Infertility Market, By Regional Outlook, 2022 & 2030 (In %)
Figure 14: United States Male Infertility Market 2023-2030 (In $ Million)
Figure 15: Canada Male Infertility Market 2023-2030 (In $ Million)
Figure 16: United Kingdom Male Infertility Market 2023-2030 (In $ Million)
Figure 17: Germany Male Infertility Market 2023-2030 (In $ Million)
Figure 18: France Male Infertility Market 2023-2030 (In $ Million)
Figure 19: Italy Male Infertility Market 2023-2030 (In $ Million)
Figure 20: Spain Male Infertility Market 2023-2030 (In $ Million)
Figure 21: Poland Male Infertility Market 2023-2030 (In $ Million)
Figure 22: Rest Of Europe Male Infertility Market 2023-2030 (In $ Million)
Figure 23: China Male Infertility Market 2023-2030 (In $ Million)
Figure 24: Japan Male Infertility Market 2023-2030 (In $ Million)
Figure 25: India Male Infertility Market 2023-2030 (In $ Million)
Figure 26: South Korea Male Infertility Market 2023-2030 (In $ Million)
Figure 27: Asean Countries Male Infertility Market 2023-2030 (In $ Million)
Figure 28: Australia & New Zealand Male Infertility Market 2023-2030 (In $ Million)
Figure 29: Rest Of Asia-pacific Male Infertility Market 2023-2030 (In $ Million)
Figure 30: Brazil Male Infertility Market 2023-2030 (In $ Million)
Figure 31: Mexico Male Infertility Market 2023-2030 (In $ Million)
Figure 32: Rest Of Latin America Male Infertility Market 2023-2030 (In $ Million)
Figure 33: United Arab Emirates Male Infertility Market 2023-2030 (In $ Million)
Figure 34: Turkey Male Infertility Market 2023-2030 (In $ Million)
Figure 35: Saudi Arabia Male Infertility Market 2023-2030 (In $ Million)
Figure 36: South Africa Male Infertility Market 2023-2030 (In $ Million)
Figure 37: Rest Of Middle East & Africa Male Infertility Market 2023-2030 (In $ Million)